The DOI matches its Crossref record.
Subcutaneous Morphine for Dyspnea in Cancer Patients
Abstract
Brief Reports1 November 1993Subcutaneous Morphine for Dyspnea in Cancer PatientsEduardo Bruera, MD, Tara MacEachern, RN, BScN, Carla Ripamonti, MD, and John Hanson, MScEduardo Bruera, MDFrom Edmonton General Hospital, Edmonton, Alberta, Canada, Cross Cancer Institute, Edmonton, Alberta, Canada, and National Cancer Institute, Milano, Italy., Tara MacEachern, RN, BScNFrom Edmonton General Hospital, Edmonton, Alberta, Canada, Cross Cancer Institute, Edmonton, Alberta, Canada, and National Cancer Institute, Milano, Italy., Carla Ripamonti, MDFrom Edmonton General Hospital, Edmonton, Alberta, Canada, Cross Cancer Institute, Edmonton, Alberta, Canada, and National Cancer Institute, Milano, Italy., and John Hanson, MScFrom Edmonton General Hospital, Edmonton, Alberta, Canada, Cross Cancer Institute, Edmonton, Alberta, Canada, and National Cancer Institute, Milano, Italy.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-119-9-199311010-00007 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Dyspnea has been defined as an uncomfortable awareness of breathing [1]. It occurs in approximately 29% to 74% of patients with terminal cancer [2, 3] and is perceived as one of the most devastating symptoms by the patient and the family. Controlled single-dose trials have suggested that opioids are effective in the management of dyspnea associated with chronic obstructive lung disease [4]. However, opioids were poorly tolerated in these patients during repeated administration, mostly because of sedation and nausea [5]. These side effects usually disappear with the development of tolerance and are rarely a cause for discontinuing treatment among the ...References1. Wasserman K, Casaburi R. Dyspnea: physiological and pathophysiological mechanisms. Annu Rev Med. 1988; 39:503-15. Google Scholar2. Reuben DB, Mor V. Dyspnea in terminally ill cancer patients. Chest. 1986; 89:234-6. Google Scholar3. Billings JA. Dyspnea, cough and other respiratory symptoms. In: Billings JA, ed. Outpatient Management of Advanced Cancer. Philadelphia: J.B. Lippincott; 1985:83. Google Scholar4. Woodcock AA, Gross ER, Gellert A, Shah S, Johnson M, Geddes DM. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med. 1981; 305:1611-6. Google Scholar5. Woodcock A, Gross E, Gellery A. A comparison of diazepam and promethazine in the treatment of breathlessness in patients with chronic obstructive lung disease. Br Med J. 1982; 1:96. Google Scholar6. Foley KM. The treatment of cancer pain. N Engl J Med. 1985; 313: 84-95. Google Scholar7. Bruera E, Macmillan K, Pither J, MacDonald RN. Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage. 1990; 5:341-4. Google Scholar8. Folstein MF, Fetting JH, Lobo A, Niaz U, Capozzoli KD. Cognitive assessment of cancer patients. Cancer. 1984; 53(10 Suppl):2250-7. Google Scholar Author, Article, and Disclosure InformationAuthors: Eduardo Bruera, MD; Tara MacEachern, RN, BScN; Carla Ripamonti, MD; John Hanson, MScAffiliations: From Edmonton General Hospital, Edmonton, Alberta, Canada, Cross Cancer Institute, Edmonton, Alberta, Canada, and National Cancer Institute, Milano, Italy.Corresponding Author: Eduardo Bruera, MD, Edmonton General Hospital, Palliative Care Program, Room 9Y39, 11111 Jasper Avenue, Edmonton, Alberta, T5K 0L4, Canada. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited bySystemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational StudyPostoperative pain management in non-traumatic emergency general surgery: WSES-GAIS-SIAARTI-AAST guidelinesEffect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary DiseaseEvaluation of diagnostic and treatment approaches to acute dyspnea in a palliative care setting among medical doctors with different educational levelsDyspneaDyspneaProphylaxis and treatment of cancer-related dyspnea with pharmacologic agents: A systematic review and network meta-analysisStudy protocol for a randomised, placebo-controlled, single-blind phase II study of the efficacy of morphine for dyspnoea in patients with interstitial lung disease (JORTC-PAL 15)Management of Dyspnea in Advanced Cancer: ASCO GuidelinePharmacologic Interventions for Breathlessness in Patients With Advanced CancerOncologic Emergencies: Palliative Care in the Emergency Department SettingEfficacy and Safety of Opioids in Treating Cancer-Related Dyspnea: A Systematic Review and Meta-Analysis Based on Randomized Controlled TrialsEnd-of-life home care of an interstitial pneumonia patient supported by high-flow nasal cannula therapy: A case reportUse of short-acting opioids in the management of breathlessness: an evidence-based reviewMorphine for the symptomatic reduction
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Parshall, M. B., Schwartzstein, R. M., Adams, L., Banzett, R. B., Manning, H. L., Bourbeau, J., Calverley, P. M., Gift, A. G., Harver, A., Lareau, S. C., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2042st · Cited by 1,844
Lanken, P. N., Terry, P. B., DeLisser, H. M., Fahy, B. F., Hansen-Flaschen, J., Heffner, J. E., Levy, M., Mularski, R. A., Osborne, M. L., Prendergast, T. J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-587st · Cited by 713
Maltoni, M., Caraceni, A., Brunelli, C., Broeckaert, B., Christakis, N., Eychmueller, S., Glare, P., Nabal, M., Viganò, A., Larkin, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.866 · Cited by 664
A systematic review of the use of opioids in the management of dyspnoea
Jennings, A.-L. (2002) · Thorax · doi:10.1136/thorax.57.11.939 · Cited by 644
Evidence for Improving Palliative Care at the End of Life: A Systematic Review
Lorenz, K. A., Lynn, J., Dy, S. M., Shugarman, L. R., Wilkinson, A., Mularski, R. A., Morton, S. C., Hughes, R. G., Hilton, L. K., Maglione, M., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-2-200801150-00010 · Cited by 591
Metadata
- Authors
- Bruera, E., MacEachern, T., Ripamonti, C., & Hanson, J.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1993-11-01
- Volume
- 119
- Issue
- 9
- Pages
- 906-907
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1998298262
- Cited by
- 212
- References
- 0
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Subcutaneous Morphine for Dyspnea in Cancer Patients. https://app.cochat.ai/papers/10.7326/0003-4819-119-9-199311010-00007
- The paper
- Bruera, E., MacEachern, T., Ripamonti, C., & Hanson, J. (1993). Subcutaneous Morphine for Dyspnea in Cancer Patients. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-119-9-199311010-00007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.